Tumor Immunology and Cancer Immunotherapy
Explores the tumor-immune microenvironment and modern approaches to cancer immunotherapy, covering basic and translational science driving immuno-oncology.
Summary
Lectures are small, with a median of 2 enrolled students in the recorded sections.
What you’ll be able to do
Demonstrate understanding of innate and adaptive immune interactions with tumors
Apply understanding of immunology to understand immunotherapeutic approaches in cancer
Compare and contrast therapeutic mechanisms of diverse immunotherapies
Demonstrate knowledge of the patterns and rates of response to immunotherapies among distinct cancers
Demonstrate understanding of immunotherapy toxicities and approaches to treating these
Apply and adapt understanding of tumor immunology and current immunotherapies to devise a proposal for next generation approach to cancer immunotherapy
Source: UW Guide
Grade history
↗No recorded grade history.
All recorded terms · compare terms & instructors
Prerequisites
Course mapMED SC-M 810, 811, 812, and 813
This is a best-effort interpretation; check the catalog requirements above.
Prerequisite text tree
Professors
Spring 2027No instructors recorded for this selection.
Historical instructors & teaching patterns
Recorded history may be incomplete and does not establish a future schedule.
Calendar & sections
Spring 2027Schedule loads here as you scroll.
| Section | Mode | Enrolled / capacity | Waitlist |
|---|
Times are Central. Select a meeting for details; export includes recorded dates for the selected sections.
Meeting source records
Student experience
the class
Gain a greater understanding of the basic and translational science that is fueling the ongoing immuno-oncology revolution in cancer care. Explore the tumor-immune microenvironment and modern approaches to cancer immunotherapy. Evaluate pertinent primary literature in this arena and exposure to the technological resources (e.g. flow cytometry, clinical pathology, cell therapeutics infrastructure) that are critical to implementing immunotherapies in the clinic. Tumor board attendance will highlight the clinical reasoning and toxicity management in the clinical use of immunotherapies for cancer treatment.
difficulty & workload
No workload feedback recorded.
Topics
- Tumor-immune microenvironment
- Technological resources for immunotherapy implementation
- Clinical reasoning and toxicity management
- Patterns and rates of response to immunotherapies
Skills
- Understanding innate and adaptive immune interactions with tumors
- Comparing therapeutic mechanisms of diverse immunotherapies
- Managing immunotherapy toxicities
- Clinical reasoning in immunotherapy treatment
Grades
Grade distribution · % of letter grades
No grades available yet.
More grade details Grade mix, volume & source data
Sources & history
Catalog & offerings
Descriptions, prerequisites, and recorded course offerings.
Catalog observation history
Observations at scan time; dates do not imply when a catalog change took effect.
Selected offering source records
No offering records for the selected term.
Raw records
[]
Student reviews
Original comments behind the course and instructor summaries.
Read original reviews
No records available.
Grade history
Recorded grade distributions by term, section, and instructor.
Explore recorded gradesRecorded 2026-10-14
Model outputs & technical records
LLM outputs across runs
Full model traces
Recorded model configuration, reasoning, and tool conversations.
Model & dataset provenance
{
"model": "Qwen/Qwen3.8-27B",
"model_revision": "1d4bf0f2ff6012fd82039f2fa52739d0dd7c60c0",
"task_version": "17",
"output_id": "39ccb4e565e9cef2a361fc06c257139723ef260e346ecd1d3438b4e272bb250e",
"requirements_status": "valid",
"dataset_revision": "fc1811fa52e581ea57a35c0cf3343f8740a8ffbf",
"observed_at": "2026-10-14 17:50:09.728220+00:00"
}